Efficas leverages science to develop a deeper understanding of the mechanism of action of bioactives and their ability to modulate immune system function to provide health benefits. Efficas then applies biochemistry, chemistry and molecular biology to identify biologically active compounds that will be used for the nutritional management of the immune system.

Efficas is focused on the development phase of innovation, and uses internal expertise and understanding of clinical research, product development and process technology. The company employs cutting-edge technology to substantiate effectiveness and safety for its bioactive candidates that support the nutritional management of immune function.

Tools:
Efficas uses state-of-the-art tools which include animal cell culture, detection and quantification of immune cell subtypes, allergen specific immunoglobulins, and inflammatory mediators (including cytokines, chemokines and eicosanoids), quantitative analysis of gene transcription and translation, as well as use of gene array profiling for identification of those genes that are upregulated or downregulated by the bioactive compounds.